Skip to main content
. 2018 Dec 17;374(1765):20180156. doi: 10.1098/rstb.2018.0156

Table 2.

Growth factors and tumour oncogenes/suppressors modulating macropinocytosis.

protein activity in macropinocytosis associated cancer reference
Ras membrane ruffling, macropinosome formation and trafficking pancreas, biliary tract, large intestine, small intestine, lung, ovary reviewed in Prior et al. [78]
Rac1 membrane ruffling skin melanomas Krauthammer et al. [79]
PI3 K membrane ruffle extension, macropinosome formation large intestine, central nervous system,
gastric, breast, endometrium, lung,
head and neck cancers
Samuels et al. [80]
Bauer et al. [81]
PTEN PI3 signalling pathway antagonist endometrium, brain, skin, prostate reviewed in Bauer et al. [81]
neurofibromin (NF1) RasGAP/Ras inhibitor neurofibromatosis type 1 Bloomfield et al. [82]
EGF/EGFR MP initiation lung, colon, breast, ovary, brain, head and neck reviewed in Normanno et al. [83]
CXCL12/CXCR4 MP initiation pituitary tumour, familial chronic lymphocytic leukaemia, breast, gastric, pancreas, ovary, colon reviewed in Guo et al. [84]